€24.60
0.00% yesterday
Xetra, Jun 27, 05:36 pm CET
ISIN
DE000A0LBFE4
Symbol
M3V
Index

MeVis Medical Solutions Stock price

€24.60
-0.60 2.38% 1M
-0.20 0.81% 6M
-0.60 2.38% YTD
-2.00 7.52% 1Y
-8.60 25.90% 3Y
-10.80 30.51% 5Y
+2.11 9.38% 10Y
-26.28 51.65% 20Y
Xetra, Closing price Fri, Jun 27 2025
+0.00 0.00%
ISIN
DE000A0LBFE4
Symbol
M3V
Index
Sector

Key metrics

Basic
Market capitalization
€44.8m
Enterprise Value
€38.2m
Net debt
€-6.5m
Cash
€6.5m
Shares outstanding
1.8m
Valuation (TTM | estimate)
P/E
9.84 | -
P/S
2.64 | -
EV/Sales
2.25 | -
EV/FCF
-
P/B
2.51
Dividends
DPS
€0.95
Yield 1Y | 5Y
3.86% | 1.22%
Growth 1Y | 5Y
100.00% | -
Payout 1Y | 3Y
37.85% | 10.01%
Increased
1 Year
Financials (TTM | estimate)
Revenue
€17.0m | -
EBITDA
€4.1m | -
EBIT
€4.0m
Net Income
€4.6m | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-2.13% | -
EBITDA
-17.40% | -
EBIT
-18.41%
Net Income
-7.32% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
97.12%
EBITDA
24.36% | -
EBIT
23.58%
Net
26.87% | -
Free Cash Flow
-
Financial Health
Equity Ratio
67.31%
Return on Equity
25.59%
ROCE
19.89%
ROIC
28.64%
Debt/Equity
0.00
More
EPS
€2.50
FCF per Share
Short interest
-
Employees
100.00
Rev per Employee
€170.00k
Show more

Is MeVis Medical Solutions a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

MeVis Medical Solutions Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a MeVis Medical Solutions forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a MeVis Medical Solutions forecast:

Hold
43%
Sell
57%

Financial data from MeVis Medical Solutions

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
17 17
2% 2%
100%
- Direct Costs 0.49 0.49
9% 9%
3%
16 16
2% 2%
97%
- Selling and Administrative Expenses 11 11
3% 3%
66%
- Research and Development Expense - -
-
-
4.13 4.13
17% 17%
24%
- Depreciation and Amortization 0.13 0.13
30% 30%
1%
EBIT (Operating Income) EBIT 4 4
18% 18%
24%
Net Profit 4.56 4.56
7% 7%
27%

In millions EUR.

Don't miss a Thing! We will send you all news about MeVis Medical Solutions directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MeVis Medical Solutions Stock News

AD HOC NEWS
about one month ago
MeVis Medical Solutions AG / DE000A0LBFE4
AD HOC NEWS
about one month ago
MeVis Medical Solutions AG / DE000A0LBFE4
EQS
5 months ago
Der Umsatz im abgelaufenen Geschäftsjahr 2023/2024 belief sich auf € 17,0 Mio. (gegenüber € 17,3 Mio. im Geschäftsjahr 2022/2023). Die Umsatzerlöse entfallen zu 25 % (i. Vj. 26 %) auf die Veräußerung von Lizenzen, zu 35 % (i. Vj. 36 %) auf Wartungsumsätze und zu 40 % (i. Vj. 38 %) auf übrige Umsä...
More MeVis Medical Solutions News

Company Profile

MeVis Medical Solutions AG engages in the development of software for analyzing and evaluation image data for manufacturers of medical devices and providers of medical information technology platforms. It operates through Digital Mammography, Development Services and Other Operating Activities segments. The Digital Mammography segment develops and markets software products, which support breast diagnostic imaging and intervention. The Development Services segment comprises the assignment of software development teams, i.e. software developers, product and project managers, application specialists and test engineers, for the contract development of software modules for external customers. The segment Other Operating Activities includes the lung, liver, neuro and MeVis Online Services product areas. The company was founded by Carl J.G. Evertsz and Heinz-Otto Peitgen in 1997 and is headquartered in Bremen, Germany.

Head office Germany
CEO Marcus Kirchhoff
Employees 100
Founded 1997
Website www.mevis.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today